Point72 Hong Kong’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,291
Closed -$485K 1833
2022
Q3
$485K Buy
+10,291
New +$665K 0.02% 757
2021
Q2
Sell
-5,814
Closed -$441K 2457
2021
Q1
$441K Buy
+5,814
New +$438K 0.01% 883
2020
Q3
Sell
-2,455
Closed -$143K 1623
2020
Q2
$143K Buy
+2,455
New +$132K 0.02% 565
2017
Q4
Sell
-26
Closed -$1K 1144
2017
Q3
$1K Buy
+26
New +$1.45K ﹤0.01% 738
2017
Q1
Sell
-85
Closed -$4K 1064
2016
Q4
$4K Buy
+85
New +$4.12K ﹤0.01% 740

Other funds holding SYNH

Point72 Hong Kong's SYNH Position: Q4 2022 in Review

Point72 Hong Kong sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 10,291 shares — an estimated $485K sold.

Point72 Hong Kong first reported a position in SYNH in Q4 2016 and held it in 5 quarters. The position peaked at $485K in Q3 2022. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Point72 Hong Kong reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 10,291 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $485K.
  • Point72 Hong Kong first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 5 quarters.
  • Point72 Hong Kong's Syneos Health, Inc. Class A Common Stock position peaked at $485K in Q3 2022.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.